Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Forensic Analyst

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Forensic Accounting

Affle 3i Limited is a global technology company that provides a consumer intelligence platform, delivering consumer engagements, acquisitions, and transactions through mobile advertising. The company operates on a Cost Per Converted User (CPCU) model, transforming online and offline user data into actionable insights for brands. It was incorporated in 1994 and is headquartered in Gurugram, India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/affle-3i-limited" target="_blank" data-smartkarma-citation="entities:28934:1" rel="noopener">Affle 3i (AFFLE IN)</a> 's revenue recognition accounting differs from the peers despite same business model. Rising unbilled revenues coupled with a sharp increase in bad debts strike concerns.</li>
<li>Affle’s capitalisation rate of product-development costs has also increased over the last five years; standing above peers and supporting margins amidst slowdown in revenue growth.</li>
<li>Accounting prudence also remains under question for acquisitions. Investment in Bobble continues to be carried in full despite impairment risks while Appnext’s restructuring is interesting amid losses.</li>
</ul>



Affle 3i (AFFLE IN) 's revenue recognition accounting differs from the peers despite same business model. Rising unbilled revenues coupled with a sharp increase in bad debts strike concerns.
Affle’s capitalisation rate of product-development costs has also increased over the last five years; standing above peers and supporting margins amidst slowdown in revenue growth.
Accounting prudence also remains under question for acquisitions. Investment in Bobble continues to be carried in full despite impairment risks while Appnext’s restructuring is interesting amid losses.


Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Market & Forensics Analyst

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

United Spirits Ltd. manufactures and distributes alcoholic beverages. The Company provides a variety of alcohols and spirits, including whiskey, brandy, and rum. United Spirits also manufactures indian-made foreign liquor brands. United Spirits serves customers worldwide.

<ul>
<li>The Board wiped out a historic INR 1,238 crore loan to United Breweries (Holdings) Limited (UBHL) in March 2026, abandoning INR 1,343 crore in unrecognised interest.</li>
<li>Auditors have maintained an ‘Emphasis of Matter’ regarding fund diversions to the former non-executive Chairman’s entities for six consecutive years.</li>
<li>The SFIO launched a formal inquiry in FY2026 into historic fund diversions, signaling that legacy regulatory risks are far from resolved despite recent settlements with the MCA.</li>
</ul>


The Board wiped out a historic INR 1,238 crore loan to United Breweries (Holdings) Limited (UBHL) in March 2026, abandoning INR 1,343 crore in unrecognised interest.
Auditors have maintained an ‘Emphasis of Matter’ regarding fund diversions to the former non-executive Chairman’s entities for six consecutive years.
The SFIO launched a formal inquiry in FY2026 into historic fund diversions, signaling that legacy regulatory risks are far from resolved despite recent settlements with the MCA.


United Spirits Governance Issue:  ₹1,238 Crore Write-Off & Pending Cases

Aether Industries is an Indian specialty chemical manufacturer that produces advanced intermediates and specialty chemicals for various industries, including pharmaceuticals, agrochemicals, material sciences, and oil & gas. The company operates through large-scale manufacturing, contract research and manufacturing services (CRAMS), and contract/exclusive manufacturing business models. It was founded in 2013 and is headquartered in Surat, Gujarat, India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/aether-industries-ltd" target="_blank" data-smartkarma-citation="entities:36096:1" rel="noopener">Aether Industries (AETHER IN)</a> ’s INR20.6 bn capex cycle is now yielding strong growth and 31.3% EBITDA margins; however, reported profitability is partly influenced by accounting judgements w.r.t. fire incidents.</li>
<li>Underlying cash conversion remains weak at 39% of adjusted EBITDA over FY20–FY26, further questioning the earnings quality.</li>
<li>Execution delays, promoter-linked transactions and unusual cost allocation at ASCL introduce additional questions that need explanation.</li>
</ul>



Aether Industries (AETHER IN) ’s INR20.6 bn capex cycle is now yielding strong growth and 31.3% EBITDA margins; however, reported profitability is partly influenced by accounting judgements w.r.t. fire incidents.
Underlying cash conversion remains weak at 39% of adjusted EBITDA over FY20–FY26, further questioning the earnings quality.
Execution delays, promoter-linked transactions and unusual cost allocation at ASCL introduce additional questions that need explanation.


Aether Industries Ltd: The Other Side of Growth

Jubilant Ingrevia Limited is a global integrated life science products and innovative solutions provider. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers with specialty chemicals, nutrition and health solutions, and chemical intermediates. It offers a broad portfolio of high-quality ingredients and provides custom development and manufacturing services for pharmaceutical and agrochemical clients. Jubilant Ingrevia is headquartered in Noida, Uttar Pradesh, India, and was incorporated on October 23, 2019.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/jubilant-ingrevia-ltd" target="_blank" data-smartkarma-citation="entities:45231:1" rel="noopener">Jubilant Ingrevia (JUBLINGR IN)</a> ’s Business Mix is improving with Specialty Chemicals driving 75% of EBITDA; however, capital efficiency remains subdued as asset turnover and ROCE have yet to recover.</li>
<li>Balance-Sheet health remains comfortable, but capital allocation warrants scrutiny given excess cash in current accounts, rising contingent liabilities and potential under-utilisation of newly commissioned Bharuch capacity. </li>
<li>Earnings quality has watchpoints, including rising receivables, sizeable non-core income, profit-linked promoter remuneration and nominal-priced ESOPs, though no strong aggregate manipulation signal emerges.</li>
</ul>



Jubilant Ingrevia (JUBLINGR IN) ’s Business Mix is improving with Specialty Chemicals driving 75% of EBITDA; however, capital efficiency remains subdued as asset turnover and ROCE have yet to recover.
Balance-Sheet health remains comfortable, but capital allocation warrants scrutiny given excess cash in current accounts, rising contingent liabilities and potential under-utilisation of newly commissioned Bharuch capacity. 
Earnings quality has watchpoints, including rising receivables, sizeable non-core income, profit-linked promoter remuneration and nominal-priced ESOPs, though no strong aggregate manipulation signal emerges.


Jubilant Ingrevia- Transformation with Some Caveats

All Time Plastics Limited manufactures plastics products. The Company offers mugs, storage and laundry baskets, hangers, bathroom sets, thermos, bottles, and other plastic houseware products. All Time Plastics serves customers in India.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/all-time-plastics-limited" target="_blank" data-smartkarma-citation="entities:55510:1" rel="noopener">All Time Plastics (ALLTIME IN)</a> delivered steady growth with resilient gross margins; however, FY26 profitability weakened as geopolitical headwinds and capacity additions increased overheads, while utilisation remained subdued.</li>
<li>FY25 receivables surged 79% despite 9% revenue growth, though normalised subsequently; recurring discrepancies between books and bank-reported working capital raise concerns over periodic reporting and reconciliation controls.</li>
<li>Governance warrants attention given sizeable pre-IPO property purchases from promoters, high promoter/KMP remuneration and an unexplained INR 150 mn corporate loan.</li>
</ul>



All Time Plastics (ALLTIME IN) delivered steady growth with resilient gross margins; however, FY26 profitability weakened as geopolitical headwinds and capacity additions increased overheads, while utilisation remained subdued.
FY25 receivables surged 79% despite 9% revenue growth, though normalised subsequently; recurring discrepancies between books and bank-reported working capital raise concerns over periodic reporting and reconciliation controls.
Governance warrants attention given sizeable pre-IPO property purchases from promoters, high promoter/KMP remuneration and an unexplained INR 150 mn corporate loan.


All Time Plastics- Few Cracks in the Mould

Accounting Diagnostics, Red Flags, Short-sell risk